Samenwerkingsverband tussen IWT Vlaanderen en
het departement Economie, Wetenschap en Innovatie van de Vlaamse overheid
FP7 research funding opportunities in the field of
neuroscience
Alain Deleener - IWT
National Contact Point FP7 Health for Flanders (Belgium)
EU support for Research and Innovation
FP7 funding opportunities for neuroscience
complementary programmes, from research to market.
• The €55 billion Seventh Framework Programme supports basic and applied
research activities, still far from the market, leverages money and
concentrate resources on strategic research areas, always on the basis of
technological and scientific excellence.
• The Competitiveness and Innovation Framework Programme does not
finance research, but supports innovation activities, provides better access
to finance and delivers business support services in the regions.
• Structural funds have just as much funding as FP7, however FP7 concentrates
on excellence for competitiveness, while the Structural Funds' main objective
is cohesion.
However, there are synergies between these programmes.
2
FP7 Structure and Budget
FP7 funding opportunities for neuroscience
EC Framework Programme is delineated into four Specific Programmes;
total budget of € 50.52 billion
Euratom
Cooperation
JRC (EC)
4,061
1,751
Capacities 4,097
Ideas
(European Research Council)
People
4,75
Cooperation
32,413*
People
7,51
Ideas
Capacities
*of which Health € 6.1 billion
Total FP7 budget, including EURATOM: € 54,582 billion
Collaborative research in FP7:
The Cooperation programme
FP7 funding opportunities for neuroscience
Thematic Priorities
1.
2.
3.
4.
5.
6.
7.
8.
9.
Health
Food, agriculture, fisheries and biotechnology
Information and communication technologies
Nanosciences, nanotechnologies, materials
and new production technologies
Energy
Environment (including climate change)
Transport (including aeronautics)
Socio-economic sciences and the humanities
Security & 10. Space
Total for collaborative research
6.1
1.9
9.1
3.5
2.3
1.9
4.2
0.6
2.8
€32.4 billion
4
Cooperation – ‘Tools’
FP7 funding opportunities for neuroscience
• Under each theme there will be sufficient flexibility to address both
Emerging needs and Unforeseen policy needs
• Dissemination of knowledge and transfer of results will be supported
in all thematic areas
• Support will be implemented across all themes through:
Collaborative research
(Collaborative projects; Networks of Excellence; Coordination/support actions)
Joint Technology Initiatives
Coordination of non-Community research programmes
(ERA-NET; ERA-NET+; Article 169)
International Cooperation
Collaborative research in FP7:
The Cooperation programme
FP7 funding opportunities for neuroscience
Thematic Priorities
1.
2.
3.
4.
5.
6.
7.
8.
9.
Health
Food, agriculture, fisheries and biotechnology
Information and communication technologies
Nanosciences, nanotechnologies, materials
and new production technologies
Energy
Environment (including climate change)
Transport (including aeronautics)
Socio-economic sciences and the humanities
Security & 10. Space
6.1
1.9
9.1
3.5
2.3
1.9
4.2
0.6
2.8
Total
collaborative research
for
€32.4 billion
6
Scope of research
in the Health Theme
FP7 funding opportunities for neuroscience
• In the Health theme, the Framework programme can
support both basic and applied research
• This includes discovery activities, translational research and
clinical trials (normally only phase I and II).
Health research in FP7
FP7 funding opportunities for neuroscience
Pillar 1:
Pillar 2:
Pillar 3:
Biotechnology,
generic tools
& technologies
for health
Translating
research for
human health
Optimising
the delivery
of health care
cross-cutting issues: child health, the health of ageing population
gender-related health issues
Budget: € 6.1 billion over 7 years (2007-2013)
Public Health
Translational
Biotech
Health
Health research in FP7
1: Biotechnology, generic tools and technologies
FP7 funding opportunities for neuroscience
 High-throughput research
technologies for: sequencing (genotyping, phenotyping, gene expression)
structural / functional genomics, bioinformatics, systems biology
 Detection, diagnosis and monitoring
tools and technologies for: visualisation, imaging, detection and analysis
 Predicting suitability, safety and efficacy of therapies
pharmacogenomics, biomarkers, targeting and delivery approaches
(incl. alternatives to animal testing), and in vivo methods and models
 Innovative therapeutic approaches & intervention
Public Health
Translational
Biotech
Health
gene and cell therapy, regenerative medicine, transplantation,
immunotherapy and vaccines
Health research in FP7
2: Translating research for human health (1)
FP7 funding opportunities for neuroscience
 Integrating biological data and processes
large-scale data gathering: generate data to elucidate the function of genes
and gene products and their interaction in complex networks
systems biology: to develop and apply systems approaches to understand
and model biological processes
 Research on the brain and related diseases
to better understand the integrated structure and dynamics of the brain,
and to study brain diseases, incl age-related ones: dementia, Parkinson
 Human development and ageing
Public Health
Translational
Biotech
Health
to better understand the process of life-long development
and healthy ageing
Health research in FP7
2: Translating research for human health (2)
FP7 funding opportunities for neuroscience
 Translational research in infectious diseases:
 drug resistance
 HIV / AIDS, malaria, tuberculosis
 hepatitis
 new and re-emerging epidemics
 Translational research in major diseases: (~ 20-25% of
request)
Public Health
Translational
Biotech
Health
 cancer
 cardiovascular disease
 diabetes / obesity
 rare diseases
 other chronic diseases e.g. rheumatic, respiratory,
musculo-skeletal diseases & arthritis)
Health research in FP7
3: Optimising the delivery of health care
FP7 funding opportunities for neuroscience
 Translating clinical outcome into clinical practice
patient safety, best clinical practice, decision making in clinical settings in
primary and specialised care, foster application of evidence-based medicine
 Quality, efficiency and solidarity of health systems
organizational, financial and regulatory aspects of health systems
Public Health
Translational
Biotech
Health
 Enhanced disease prevention and better use
of medicines
provide scientific evidence for best public health measures
Work programme 2010 preparation (4th call)
Roadmap
FP7 funding opportunities for neuroscience
Strategy Paper >> DG and Commissioner (Nov.-Dec.‘08)
Reflection paper >> 1st PC meeting (12 January ‘09)
Draft WP >> 2nd PC meeting (5 March ‘09 ?)
Draft WP >> Inter-service Consultation (May)
Draft WP >> PC formal opinion (June)
Work Programme adoption (July)
& publication in July or September
Research priorities for 4th call
FP7 funding opportunities for neuroscience
Important features:
• focus on 4 key research challenges
• some areas closed
• will probably be split into 2 or 3 calls
• 2-stage submission for some areas/topics
focus on 4 Key Research Challenges
• Providing tools for translational research
• Structuring translational research in the field of
cancer
• Structuring translational research in the field of
neurodegenerative diseases.
• Better health for Africa
Funding schemes in the Health theme (4th call)
FP7 funding opportunities for neuroscience
Funding schemes
upper limits
Large-scale integrating project (CP-IP)
€12m
Network of excellence (NoE)
to be specified
Small- or medium-scale focussed research project
(CP-FP)
€3m or €6m
Coordination action (CA)
€2m
Support action (SA)
€0.5m
FP7 – Health
4th call topics (1/5)
FP7 funding opportunities for neuroscience
Biotech, tools & technologies
1.1 – High-throughput research
1. Harmonisation of phenotyping and biosampling for clinical
research.
Funding scheme: Large scale integrating project.
! Topics communicated with reservation !
FP7 – Health
4th call topics (2/5)
FP7 funding opportunities for neuroscience
Biotech, tools & technologies
1.2 – Detection, diagnosis and monitoring
1. Tools for the identification and the detection of biomarkers in clinical
samples and patients.
• Multimodality biomarker analysis
• Tools for detection, isolation and functional characterization of complexes of
interacting molecules for diagnostic purposes
• Development of new quantitative imaging biomarker(s) for monitoring
therapeutic effects and safety in chronic diseases
• High throughput molecular diagnostic imaging
• Development and implementation of quantum imaging of X-rays/Y-rays for
diagnosis
Funding scheme: Small or medium-scale focused research projects. (2-stage)
! Topics communicated with reservation !
FP7 – Health
4th call topics (3/5)
FP7 funding opportunities for neuroscience
Translating research for health
2.1 – Integrating biological data and processes:
2.1.2 – Systems biology
1. Tackling Human Diseases through Systems Biology Approaches.
Funding scheme: Large-scale integrating projects. (2-stage)
2. Creating European multidisciplinary networks to address systems biology
of basic biological processes relevant to health.
Funding scheme: Network of Excellence. (2-stage)
3. Coordination and support actions in large-scale data gathering and systems
biology.
Funding scheme: Coordinating Action.
4. Developing new and improving existing mathematical algorithms for
systems biology.
Funding scheme: SICA Small or medium-scaled focused research project
! Topics communicated with reservation !
FP7 – Health
4th call topics (4/5)
FP7 funding opportunities for neuroscience
Translating research for health
2.2.1 – Research on the Brain and related diseases:
1. Validation of strategies for treating addiction.
Funding scheme: Large scale integrating project.
2. Actions to support dissemination of scientific knowledge in
neuroscience.
Funding scheme: Supporting Action.
Also considering possible initiatives linked to Joint Programming
for research on neurodegenerative diseases.
! Topics communicated with reservation !
FP7 – Health
4th call topics (5/5)
FP7 funding opportunities for neuroscience
Translating research for health
2.2.2 – Human development and ageing:
1. Role of early-life developmental processes in longevity
determination.
Funding scheme: Large-scale integrating project. (2-stage)
2. Homeostasis in human development and its effects on lifespan.
Funding scheme: Small or medium-scale focused research
project. (2-stage)
! Topics communicated with reservation !
Collaborative research in FP7:
The Cooperation programme
FP7 funding opportunities for neuroscience
Thematic Priorities
1.
2.
3.
4.
5.
6.
7.
8.
9.
Health
Food, agriculture, fisheries and biotechnology
Information and communication technologies
Nanosciences, nanotechnologies, materials
and new production technologies
Energy
Environment (including climate change)
Transport (including aeronautics)
Socio-economic sciences and the humanities
Security & 10. Space
Total for collaborative research
6.1
1.9
9.1
3.5
2.3
1.9
4.2
0.6
2.8
€32.4 billion
21
FP7 – ICT
call topics (1/4)
FP7 funding opportunities for neuroscience
Challenge 2: Cognitive Systems and Robotics
 Objective ICT-2009.2.1: Cognitive Systems and Robotics
“Pertinent research may be informed by neuro- and behavioural
sciences and determine the requirements basic technologies have
to meet in order to enable creating the targeted systems.”
FP7 – ICT
call topics (2/4)
FP7 funding opportunities for neuroscience
Challenge 4: Towards sustainable and personalised healthcare
 Objective ICT-2009.5.1: Personal Health Systems
 Target outcome b): Mental health
ICT based solutions for persons suffering from stress, depression or bipolar
disorders (other mental disorders are not in scope).Interdisciplinary
research will address the parallel development of technological solutions,
as well as new management or treatment models based on closed-loop
approaches. Emphasis will be on the use of multiparametric monitoring
systems, which monitor various metrics related to behaviour and to bodily
and brain functions (e.g. activity, sleep, physiological and biochemical
parameters).
 Objective ICT-2009.5.3: Virtual Physiological Human
“Coordination/Support action to develop an observatory on the achievements
and evolution of the broader Biomedical Informatics field which builds on
synergies between bioinformatics, medical informatics, and neuroinformatics.
The action should incorporate intensive dissemination and training components
and facilitate communication between projects.
FP7 – ICT
call topics (3/4)
FP7 funding opportunities for neuroscience
Challenge 7: ICT for Independent Living, Inclusion and Governance
 Objective ICT-2009.7.2: Accessible and Assistive ICT
“ICT restoring and augmenting human capabilities compensating for people with
reduced motor functions or disabilities: Radically new ICT-enabled approaches to
restore and augment the ability of people in their daily life with a focus on reduced
motor functions. Research should aim for breakthroughs in the way humans interact
with computers and how they may overcome their disability and augment their
capabilities.
The research should build on progress in non-invasive sensor and actuator concepts
for brain/neuronal-computer interaction (BNCI), smart bio-sensors, selflearning/adaptive systems and advanced signal processing.”
FP7 – ICT
call topics (4/4)
FP7 funding opportunities for neuroscience
4.8 Future and Emerging Technologies (Open call – cut off dates)
Radical breakthroughs in ICT increasingly rely on fresh synergies, crosspollination and convergence with different scientific disciplines (for
instance, biology, chemistry, nanoscience, neuro- and cognitive science,
ethology, social science, economics) and with the arts and humanities.
 Objective ICT-2009.8.4: FET proactive 4: Human-Computer
Confluence.
 Objective ICT-2009.8.8: FET proactive 8: Brain Inspired ICT
 Target outcome
a) Development of multi-scale models of information processing and
communication in the brain and/or PNS.
b) Synthetic Hardware Implementations of Neural Circuits
FP7 – ICT
future calls
FP7 funding opportunities for neuroscience
Next calls in 2009
• in June (deadline October/November)
• in November (deadline beginning 2010)
• every 2 calls all topics will be open
FET : open call with cut off dates
FP7: from call to project
FP7 funding opportunities for neuroscience
Calls
proposals
e-proposal
EPSS
evaluation
ranking
EC decision
negotiation
GPF-file GA
Project
27
Evaluation & submission procedures
FP7 funding opportunities for neuroscience
•
Evaluations may follow a single or a two-step evaluation
procedure or two-stage submission procedure
•
The applicable procedure will be set out in the call
•
Two-step evaluation procedure, only proposals that pass the 1st
step, based on the evaluation against a limited set of criteria,
will go forward for further evaluation
•
Two-stage submission procedure, only applicants whose
proposals pass the evaluation for the 1st stage will be
requested to submit a complete proposal in the 2nd stage
28
Brussels 30
Jan 2007
Who can participate?
FP7 funding opportunities for neuroscience
• Any undertaking, university or research centre or other legal entity,
whether established in a:
o Member State (MS)
o Associated country (Ac) , or
o third country
• Joint Research Centre (JRC) - is deemed to be established in another
MS or Ac
• International organisations and participants from third countries can
participate only if in addition to the minima
29
Brussels 30
Jan 2007
Conditions for participation
FP7 funding opportunities for neuroscience
• Minimum condition, general rule, at least 3 independent participants
from 3 different MS or Ac
• Additional conditions can be established by the SP or WP (number or
type of participant, place of establishment)
• Specific conditions may also apply for:
o Frontier research actions, at least 1 legal entity established in a
MS or Ac
o Collaborative projects addressing the participation of
International Cooperation Partner Countries (ICPC) minimum is 4
participants, 2 of which from MS or Ac and another 2 from ICPC
countries unless otherwise foreseen in the WP
30
Brussels 30
Jan 2007
Criteria for evaluation
FP7 funding opportunities for neuroscience
• The Commission will evaluate the proposals submitted according to the
following main criteria:
o Scientific and/or technological excellence
o relevance to the topic of the call
o quality and efficiency of the implementation and management
o potential impact of project results
• Additional requirements on the application of these criteria may be added
in the work programmes
• For research actions under the IDEAS Programme the sole criterion of
excellence will apply
31
Brussels 30
Jan 2007
Eligibility for funding
FP7 funding opportunities for neuroscience
• Legal entities from MS and Ac or created under Community law and the JRC
• International European interest organisations
• Legal entities established in international cooperation partner countries
(ICPC), and
• International organisations and legal entities from third countries other than
ICPC only if:
o
provided for in SP or WP; or
o
their contribution is essential for carrying out action; or
o
provision for funding is provided for in a bilateral agreement
between Community and the third country
32
Brussels 30
Jan 2007
Upper funding limits
FP7 funding opportunities for neuroscience
Reimbursement will be according to the type of action and/or activity
• Research and technological development activities: up to 50% of eligible
costs, or up to 75% for:
• Non profit public bodies
• secondary and higher education establishments
• research organisations
• SMEs
• Security related research, for highly reliable capabilities with impact on
security of European citizens and targeted to a limited number of
public users
• Demonstration activities: up to 50%
• Other activities including management: up to 100%
• Actions that will be reimbursed up to 100%:
• Frontier research
• Coordination and support
• Training and career development of researchers
33
Brussels 30
Jan 2007
Reimbursement of eligible costs
FP7 funding opportunities for neuroscience
• Most funding schemes use reimbursement of eligible costs
o
Eligible
 actual (average personnel costs may be used if do not differ
significantly from actual)
 incurred during duration of project
 in accordance with the beneficiary usual accounting and
management principles
 recorded in the accounts of beneficiary
 used for the sole purpose of achieving the objectives of the
project
o
Non-eligible (identifiable indirect taxes including VAT…)
34
Brussels 30
Jan 2007
Indirect Cost
FP7 funding opportunities for neuroscience
• Participants may charge eligible direct and indirect costs
• Reimbursement of indirect costs :
o For all:
 either actual overhead, or simplified method, or
 flat rate of 20% of direct costs
o For Non profit Public Bodies, Secondary and Higher Education
establishments, Research Organisations, and SMEs unable to identify
real indirect costs, may apply for a flat rate of 60% for funding schemes
with Research, Technological Development & Demonstration
o For Coordination and Support Actions limit of
 7% of direct costs
35
Brussels 30
Jan 2007
How to use FP7
Do and don’t…
FP7 funding opportunities for neuroscience
• Match your objectives with the Programme funding opportunities.
Have a clear vision of what you want to get.
• Do it only if it corresponds to your strategic goals.
• Use the various supporting options….
36
Consortium size and composition
FP7 funding opportunities for neuroscience
There is no ideal size:
 whether it is for small, medium or large proposals, the consortium
must be composed of the right set of competences and resources
 large Integrating projects do not necessarily require large consortia
 there are not “political” / “geographical” requirements, although
there should not be obvious imbalances
eg: 5 out of 7 partners from same country
Key factors for success
in applying for FP7 funding
FP7 funding opportunities for neuroscience
Competition is tough: only the best projects get funded
 The proposal must be in scope with the topic
and the work programme (not wishful thinking)
 The consortium of partners must be excellent
and appropriate for the task (select the right partners)
 The proposal must address all 3 criteria
 Convince the evaluators (don’t rely on reputation)
 and, of course, respect the basic rules
(deadlines, n° participants, ceilings, length, ethics, …)